Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats

Experimental Biology and Medicine

Volumn 236, Issue 9, 2011, Pages 1064-1069

  Wang, Daxin ^a   Han, Jiju ^b   Yu, Yang ^b   Li, Xueping ^a   Wang, Yun ^b   Tian, Hua ^b   Guo, Shoudong ^b   Jin, Shiguang ^a   Luo, Tian ^b   Qin, Shucun ^b  

^a YANGZHOU UNIVERSITY   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Chitosan oligosaccharide; High density lipoprotein cholesterol; Hyperlipidemia; Lecithin cholesterol acyl transferase; Very low density lipoprotein triglyceride

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; APOLIPOPROTEIN E; CHITOSAN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LECITHIN RETINOL ACYLTRANSFERASE; OLIGOSACCHARIDE; PHOSPHOLIPID; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DYSLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; RAT; ULTRACENTRIFUGATION; UPREGULATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHITOSAN; CHOLESTEROL, HDL; CHROMATOGRAPHY, LIQUID; DIETARY FATS; LIPOPROTEINS, VLDL; MALE; RATS; RATS, WISTAR; TRIGLYCERIDES;

RATTUS; RATTUS NORVEGICUS;

EID: 80052447907     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011032     Document Type: Article

References (21)

1. Assmann G, Cullen P, Jossa F, Lewis B, Mancini M. Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler Thromb Vasc Biol 1999;19:1819-24
2. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 2005;25:2265-72
3. Negishi K, Noiri E, Maeda R, Portilla D, Sugaya T, Fujita T. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury. Kidney Int 2008;73:1374-84
4. Kostapanos MS, Milionis HJ, Elisaf MS. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Am J Cardiovasc Drugs 2010;10:11-28
5. Okuda H. Hints of western medicine from Chinese medicine. Exp Biol Med (Maywood) 2003;228:1250-5
6. Xu G, Huang X, Qiu L, Wu J, Hu Y. Mechanism study of chitosan on lipid metabolism in hyperlipidemic rats. Asia Pac J Clin Nutr 2007;16(Suppl. 1):313-7
7. Aam BB, Heggset EB, Norberg AL, Sorlie M, Varum KM, Eijsink VG. Production of chitooligosaccharides and their potential applications in medicine. Mar Drugs 2010;8:1482-517
8. Hossain S, Rahman A, Kabir Y, Shams AA, Afros F, Hashimoto M. Effects of shrimp (Macrobracium rosenbergii)-derived chitosan on plasma lipid profile and liver lipid peroxide levels in normo-and hypercholesterolaemic rats. Clin Exp Pharmacol Physiol 2007;34:170-6
9. Nam KS, Shon YH. Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J Microbiol Biotechnol 2009;19:629-33
10. Ausar SF, Morcillo M, Leon AE, Ribotta PD, Masih R, Vilaro Mainero M, Amigone JL, Rubin G, Lescano C, Castagna LF, Beltramo DM, Diaz G, Bianco ID. Improvement of HDL-and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan. J Med Food 2003;6:397-9
11. Zhang J, Liu J, Li L, Xia W. Dietary chitosan improves hypercholesterolemia in rats fed high-fat diets. Nutr Res 2008;28:383-90
12. Sumiyoshi M, Kimura Y. Low molecular weight chitosan inhibits obesity induced by feeding a high-fat diet long-term in mice. J Pharm Pharmacol 2006;58:201-7
13. Srinivasan K, Patole PS, Kaul CL, Ramarao P. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats. Methods Find Exp Clin Pharmacol 2004;26:327-33
14. Qin S, Kawano K, Bruce C, Lin M, Bisgaier C, Tall AR, Jiang X. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J Lipid Res 2000;41:269-76
15. Segrest JP, Albers JJ. Plasma lipoproteins. Part A: Preparation, structure, and molecular biology. Methods Enzymol 1986;128:1-992
16. Liu B, Liu WS, Han BQ, Sun YY. Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World J Gastroenterol 2007;13:725-31
17. Choi YJ, Kim EJ, Piao Z, Yun YC, Shin YC. Purification and characterization of chitosanase from Bacillus sp. strain KCTC 0377BP and its application for the production of chitosan oligosaccharides. Appl Environ Microbiol 2004;70:4522-31
18. Zhou TX, Chen YJ, Yoo JS, Huang Y, Lee JH, Jang HD, Shin SO, Kim HJ, Cho JH, Kim IH. Effects of chitooligosaccharide supplementation on performance, blood characteristics, relative organ weight, and meat quality in broiler chickens. Poult Sci 2009;88:593-600
19. Shen J, Ye X, Shen J, Jin B, Wang Y. Studies on the effect of chito oligosaccharide on reducing lipid and protecting liver of chito oligosaccharide in hyperlipidemia mice. J Northwest A F Univ (Nat Sci Edn) 2007;35:4
20. Muth N, Laughlin G, Von MD, Smith S, Barrett-Connor E. High-density lipoprotein subclasses are a potential intermediary between alcohol intake and reduced risk of cardiovascular disease: the Rancho Bernardo Study. Br J Nutr 2010;29:9
21. Calabresi L, Franceschini G. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans. Trends Cardiovasc Med 2010;20:50-3